Advertisement

Topics

Sample size calculations for evaluating a diagnostic test when the gold standard is missing at random.

06:00 EST 5th January 2011 | BioPortfolio

Summary of "Sample size calculations for evaluating a diagnostic test when the gold standard is missing at random."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: Statistics in medicine
ISSN: 1097-0258
Pages: 200

Links

DeepDyve research library

PubMed Articles [24893 Associated PubMed Articles listed on BioPortfolio]

Evaluating the accuracy and economic value of a new test in the absence of a perfect reference test.

Streptococcus pneumoniae (SP) pneumonia is often treated empirically as diagnosis is challenging because of the lack of a perfect test. Using BinaxNOW-SP, a urinary antigen test, as an add-on to stand...

Advantage of Eu(3+) -Doped Polystyrene Microspheres Compared with Colloidal Gold Used in Immunochromatographic Assays for the Detection of Melamine in Milk.

Colloidal gold and Eu(3+) -doped fluorescent microspheres were applied as labels to develop the immunochromatographic strips for detecting melamine in milk. Under the optimized condition, the visual d...

Power and sample size for the S:T repeated measures design combined with a linear mixed-effects model allowing for missing data.

Tango (Biostatistics 2016) proposed a new repeated measures design called the S:T repeated measures design, combined with generalized linear mixed-effects models and sample size calculations for a tes...

A Bayesian hierarchical model for network meta-analysis of multiple diagnostic tests.

To compare the accuracy of multiple diagnostic tests in a single study, three designs are commonly used (i) the multiple test comparison design; (ii) the randomized design, and (iii) the non-comparati...

Optimal adaptive group sequential design with flexible timing of sample size determination.

Flexible sample size designs, including group sequential and sample size re-estimation designs, have been used as alternatives to fixed sample size designs to achieve more robust statistical power and...

Clinical Trials [8547 Associated Clinical Trials listed on BioPortfolio]

Sample Size Definition in Cochrane Hepato-Biliary Trials

Sample size definition provides important information, allowing the groundwork for transparent reporting. The sample predefinition allows the trial to be large enough to be able to addres...

Diagnosing Natriuretic Peptide Deficiency

In this pilot study, the investigators will determine the response of the natriuretic peptide (NP) hormone system after a dose of intravenous dexamethasone (a steroid medication). The goal...

VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke

The primary study objectives are to assess the safety and feasibility of the therapy, including the surgical intervention and stimulation, as well as to provide information on the appropri...

Validation of a Smart Phone App to Non-invasively Measure the Size of Children

Smart phones are omnipresent. Apps exist to calculate size of medical equipment and doses of medication if a valid weight or age is entered. During emergency situations, these values are o...

Advanced MR Imaging of Osteoarthritis

The utility of conventional imaging in the development of new treatments for osteoarthritis (OA) is hindered by: 1. Difficulty in non-invasively evaluating the initial response to poten...

Medical and Biotech [MESH] Definitions

The number of units (persons, animals, patients, specified circumstances, etc.) in a population to be studied. The sample size should be big enough to have a high likelihood of detecting a true difference between two groups. (From Wassertheil-Smoller, Biostatistics and Epidemiology, 1990, p95)

The process of gaining approval by a government regulatory agency for DIAGNOSTIC REAGENTS AND TEST KITS. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance.

Work consisting of a clinical trial involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicine, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trial is characterized as a RANDOMIZED CONTROLLED TRIAL.

Clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterized as RANDOMIZED CONTROLLED TRIALS AS TOPIC.

Math calculations done for preparing appropriate doses of medicines, taking into account conversions of WEIGHTS AND MEASURES. Mistakes are one of the sources of MEDICATION ERRORS.

Quick Search
Advertisement
 


DeepDyve research library

Searches Linking to this Article